Conv. Plasma
Nigella Sativa

All chlorhexidine studies
Meta analysis
study COVID-19 treatment researchChlorhexidineChlorhexidine (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Antiviral Mechanism and Clinical Benefits of Mouthwash Active Against SARS-CoV-2

Brito-Reia et al., Current Oral Health Reports, doi:10.1007/s40496-024-00368-1
Feb 2024  
  Source   PDF   All Studies   Meta AnalysisMeta
46th treatment shown to reduce risk in January 2024
*, now with p = 0.00000000062 from 3 studies.
Lower risk for progression, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments.
Review of antiviral mechanisms and clinical benefits of mouthwashes for SARS-CoV-2, including chlorhexidine (CHX), cetylpyridinium chloride (CPC), ethyl lauroyl arginate (ELA), hydrogen peroxide (HP), povidone-iodine (PVP-I), and anionic phthalocyanine derivative (APD).
See Ting et al. for another review covering chlorhexidine for COVID-19.
Brito-Reia et al., 19 Feb 2024, peer-reviewed, 4 authors. Contact:
This PaperChlorhexidineAll
{ 'indexed': {'date-parts': [[2024, 5, 1]], 'date-time': '2024-05-01T13:10:44Z', 'timestamp': 1714569044670}, 'reference-count': 50, 'publisher': 'Springer Science and Business Media LLC', 'issue': '2', 'license': [ { 'start': { 'date-parts': [[2024, 2, 19]], 'date-time': '2024-02-19T00:00:00Z', 'timestamp': 1708300800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': ''}, { 'start': { 'date-parts': [[2024, 2, 19]], 'date-time': '2024-02-19T00:00:00Z', 'timestamp': 1708300800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': ''}], 'funder': [ { 'DOI': '10.13039/501100002322', 'name': 'Coordenação de Aperfeiçoamento de Pessoal de Nível Superior', 'doi-asserted-by': 'publisher', 'award': ['001']}], 'content-domain': {'domain': [''], 'crossmark-restriction': False}, 'DOI': '10.1007/s40496-024-00368-1', 'type': 'journal-article', 'created': {'date-parts': [[2024, 2, 19]], 'date-time': '2024-02-19T08:03:11Z', 'timestamp': 1708329791000}, 'page': '138-143', 'update-policy': '', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Antiviral Mechanism and Clinical Benefits of Mouthwash Active Against SARS-CoV-2', 'prefix': '10.1007', 'volume': '11', 'author': [ { 'ORCID': '', 'authenticated-orcid': False, 'given': 'Verônica Caroline Brito', 'family': 'Reia', 'sequence': 'first', 'affiliation': []}, { 'ORCID': '', 'authenticated-orcid': False, 'given': 'Bernardo', 'family': 'da Fonseca Orcina', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': '', 'authenticated-orcid': False, 'given': 'Fabiano Vieira', 'family': 'Vilhena', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': '', 'authenticated-orcid': False, 'given': 'Paulo Sérgio', 'family': 'da Silva Santos', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 2, 19]]}, 'reference': [ { 'issue': '2', 'key': '368_CR1', 'doi-asserted-by': 'publisher', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'volume': '181', 'author': 'M Hoffmann', 'year': '2020', 'unstructured': 'Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry ' 'depends on ACE2 and TMPRSS2 and is blocked by a clinically proven ' 'protease inhibitor. Cell. 2020;181(2):271-280.e8. ' '', 'journal-title': 'Cell'}, { 'key': '368_CR2', 'doi-asserted-by': 'publisher', 'first-page': '580796', 'DOI': '10.3389/fmed.2020.580796', 'volume': '7', 'author': 'M Zhong', 'year': '2020', 'unstructured': 'Zhong M, Lin B, Pathak JL, et al. ACE2 and furin expressions in oral ' 'epithelial cells possibly facilitate COVID-19 infection via respiratory ' 'and fecal-oral routes. Front Med (Lausanne). 2020;7:580796. ' '', 'journal-title': 'Front Med (Lausanne)'}, { 'issue': '12', 'key': '368_CR3', 'doi-asserted-by': 'publisher', 'first-page': 'e12923', 'DOI': '10.1111/cpr.12923', 'volume': '53', 'author': 'L Chen', 'year': '2020', 'unstructured': 'Chen L, Zhao J, Peng J, et al. Detection of SARS-CoV-2 in saliva and ' 'characterization of oral symptoms in COVID-19 patients. Cell Prolif. ' '2020;53(12):e12923.', 'journal-title': 'Cell Prolif'}, { 'issue': '5', 'key': '368_CR4', 'doi-asserted-by': 'publisher', 'first-page': '892', 'DOI': '10.1038/s41591-021-01296-8', 'volume': '27', 'author': 'N Huang', 'year': '2020', 'unstructured': 'Huang N, Pérez P, Kato T, et al. SARS-CoV-2 infection of the oral cavity ' 'and saliva. Nat Med. 2020;27(5):892–903. ' '', 'journal-title': 'Nat Med'}, { 'issue': '1', 'key': '368_CR5', 'doi-asserted-by': 'publisher', 'first-page': '1848135', 'DOI': '10.1080/20002297.2020.1848135', 'volume': '13', 'author': 'BF Matuck', 'year': '2020', 'unstructured': 'Matuck BF, Dolhnikoff M, Maia GV, et al. Periodontal tissues are targets ' 'for Sars-Cov-2: a post-mortem study. J Oral Microbiol. ' '2020;13(1):1848135.', 'journal-title': 'J Oral Microbiol'}, { 'issue': '8', 'key': '368_CR6', 'doi-asserted-by': 'publisher', 'first-page': '989', 'DOI': '10.1177/0022034520918518', 'volume': '99', 'author': 'J Xu', 'year': '2020', 'unstructured': 'Xu J, Li Y, Gan F, Du Y, Yao Y. Salivary glands: potential reservoirs ' 'for COVID-19 asymptomatic infection. J Dent Res. 2020;99(8):989. ' '', 'journal-title': 'J Dent Res'}, { 'issue': '3', 'key': '368_CR7', 'doi-asserted-by': 'publisher', 'first-page': '239', 'DOI': '10.1002/path.5679', 'volume': '254', 'author': 'BF Matuck', 'year': '2021', 'unstructured': 'Matuck BF, Dolhnikoff M, Duarte-Neto AN, et al. Salivary glands are a ' 'target for SARS-CoV-2: a source for saliva contamination. J Pathol. ' '2021;254(3):239–43.', 'journal-title': 'J Pathol'}, { 'issue': '4', 'key': '368_CR8', 'doi-asserted-by': 'publisher', 'first-page': '1126', 'DOI': '10.3390/jcm9041126', 'volume': '9', 'author': 'F Carrouel', 'year': '2020', 'unstructured': 'Carrouel F, Conte MP, Fisher J, Gonçalves LS, Dussart C, Llodra JC, ' 'Bourgeois D. COVID-19: a recommendation to examine the effect of ' 'mouthrinses with β-cyclodextrin combined with citrox in preventing ' 'infection and progression. J Clin Med. 2020;9(4):1126. ' '', 'journal-title': 'J Clin Med'}, { 'key': '368_CR9', 'doi-asserted-by': 'publisher', 'first-page': '167', 'DOI': '10.1016/S0927-7757(02)00404-1', 'volume': '214', 'author': 'ZE Proverbio', 'year': '2003', 'unstructured': 'Proverbio ZE, Bardavid SM, Arancibia EL, Schulz PC. Hydrophile–lipophile ' 'balance and solubility parameter of cationic surfactants. Colloids ' 'Surfaces A: Physicochem Eng Asp. 2003;214:167–71. ' '', 'journal-title': 'Colloids Surfaces A: Physicochem Eng Asp'}, { 'issue': '3', 'key': '368_CR10', 'doi-asserted-by': 'publisher', 'first-page': '171', 'DOI': '10.1111/omi.12408', 'volume': '38', 'author': 'F D’Amico', 'year': '2023', 'unstructured': 'D’Amico F, Moro M, Saracino M, Marmiere M, Cilona MB, Lloyd-Jones G, ' 'Zangrillo A. Efficacy of cetylpyridinium chloride mouthwash against ' 'SARS-CoV-2: a systematic review of randomized controlled trials. Mol ' 'Oral Microbiol. 2023;38(3):171–80.', 'journal-title': 'Mol Oral Microbiol'}, { 'issue': '6', 'key': '368_CR11', 'doi-asserted-by': 'publisher', 'first-page': '100208', 'DOI': '10.1016/j.jlr.2022.100208', 'volume': '63', 'author': 'Z Saud', 'year': '2022', 'unstructured': 'Saud Z, Tyrrell VJ, Zaragkoulias A, Protty MB, Statkute E, Rubina A, et ' 'al. The SARS-CoV2 envelope differs from host cells, exposes procoagulant ' 'lipids, and is disrupted in vivo by oral rinses. J Lipid Res. ' '2022;63(6):100208.', 'journal-title': 'J Lipid Res'}, { 'issue': '6', 'key': '368_CR12', 'doi-asserted-by': 'publisher', 'first-page': '800', 'DOI': '10.1016/j.ajoms.2022.04.001', 'volume': '34', 'author': 'N Okamoto', 'year': '2022', 'unstructured': 'Okamoto N, Saito A, Okabayashi T, Komine A. Virucidal activity and ' 'mechanism of action of cetylpyridinium chloride against SARS-CoV-2. J ' 'Oral Maxillofac Surg Med Pathol. 2022;34(6):800–4. ' '', 'journal-title': 'J Oral Maxillofac Surg Med Pathol'}, { 'issue': '2', 'key': '368_CR13', 'doi-asserted-by': 'publisher', 'first-page': '305', 'DOI': '10.1007/s15010-020-01563-9', 'volume': '49', 'author': 'CJ Seneviratne', 'year': '2021', 'unstructured': 'Seneviratne CJ, Balan P, Ko KKK, Udawatte NS, Lai D, Ng DHL, et al. ' 'Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: ' 'randomized control trial in Singapore. Infection. 2021;49(2):305–11. ' '', 'journal-title': 'Infection'}, { 'issue': '1', 'key': '368_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1794363', 'DOI': '10.1080/20002297.2020.1794363', 'volume': '12', 'author': 'MS Moosavi', 'year': '2020', 'unstructured': 'Moosavi MS, Aminishakib P, Ansari M. Antiviral mouthwashes: possible ' 'benefit for COVID-19 with evidence-based approach. J Oral Microbiol. ' '2020;12(1):1794363.', 'journal-title': 'J Oral Microbiol'}, { 'issue': '4', 'key': '368_CR15', 'doi-asserted-by': 'publisher', 'first-page': '431', 'DOI': '10.15644/asc54/4/10', 'volume': '54', 'author': 'T Testori', 'year': '2020', 'unstructured': 'Testori T, Wang HL, Basso M, Bordini G, Dian A, Vitelli C, Miletic I, ' 'Del Fabbro M. COVID-19 and oral surgery: a narrative review of ' 'preoperative mouth rinses. Acta Stomatol Croat. 2020;54(4):431–41. ' '', 'journal-title': 'Acta Stomatol Croat'}, { 'key': '368_CR16', 'doi-asserted-by': 'publisher', 'first-page': '110436', 'DOI': '10.1016/j.mehy.2020.110436', 'volume': '146', 'author': 'INR Reis', 'year': '2021', 'unstructured': 'Reis INR, do Amaral GCLS, das Mendoza AAH, Graças YT, Mendes-Correa MC, ' 'Romito GA, Pannuti CM. Can preprocedural mouthrinses reduce SARS-CoV-2 ' 'load in dental aerosols? Med Hypotheses. 2021;146:110436. ' '', 'journal-title': 'Med Hypotheses'}, { 'issue': '3', 'key': '368_CR17', 'doi-asserted-by': 'publisher', 'first-page': '874', 'DOI': '10.1177/00220345900690030901', 'volume': '69', 'author': 'D Bernstein', 'year': '1990', 'unstructured': 'Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W. In vitro ' 'virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J ' 'Dent Res. 1990;69(3):874–6. ' '', 'journal-title': 'J Dent Res'}, { 'issue': '20', 'key': '368_CR18', 'doi-asserted-by': 'publisher', 'first-page': 'e195', 'DOI': '10.3346/jkms.2020.35.e195', 'volume': '35', 'author': 'JG Yoon', 'year': '2020', 'unstructured': 'Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, Noh JY, Cheong HJ, ' 'Kim WJ. Clinical significance of a high SARS-CoV-2 viral load in the ' 'saliva. J Korean Med Sci. 2020;35(20):e195. ' '', 'journal-title': 'J Korean Med Sci'}, { 'issue': '6', 'key': '368_CR19', 'doi-asserted-by': 'publisher', 'first-page': 'e07346', 'DOI': '10.1016/j.heliyon.2021.e07346', 'volume': '7', 'author': 'FP Eduardo', 'year': '2021', 'unstructured': 'Eduardo FP, Corrêa L, Heller D, Daep CA, Benitez C, Malheiros Z, Stewart ' 'B, Ryan M, Machado CM, Hamerschlak N, Rebello Pinho JR, Bezinelli LM. ' 'Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized ' 'pilot clinical trial. Heliyon. 2021;7(6):e07346. ' '', 'journal-title': 'Heliyon'}, { 'key': '368_CR20', 'doi-asserted-by': 'publisher', 'first-page': '363', 'DOI': '10.1016/j.fct.2013.02.018', 'volume': '56', 'author': 'M Aznar', 'year': '2013', 'unstructured': 'Aznar M, Gómez-Estaca J, Vélez D, Devesa D, Nerín C. Migrants ' 'determination and bioaccessibility study of ethyl lauroyl arginate (LAE) ' 'from a LAE-based antimicrobial food packaging material. Food Chem ' 'Toxicol. 2013;56:363–70.', 'journal-title': 'Food Chem Toxicol'}, { 'issue': '8', 'key': '368_CR21', 'doi-asserted-by': 'publisher', 'first-page': '740', 'DOI': '10.1111/jcpe.12428', 'volume': '42', 'author': 'JT Gallob', 'year': '2015', 'unstructured': 'Gallob JT, Lynch M, Charles C, Ricci-Nittel D, Mordas C, Gambogi R, ' 'Revankar R, Mutti B, Labella R. A randomized trial of ethyl lauroyl ' 'arginate-containing mouthrinse in the control of gingivitis. J Clin ' 'Periodontol. 2015;42(8):740–7.', 'journal-title': 'J Clin Periodontol'}, { 'key': '368_CR22', 'doi-asserted-by': 'publisher', 'unstructured': 'O’Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, Jones SA, et ' 'al. Potential role of oral rinses targeting the viral lipid envelope in ' 'SARS-CoV-2 infection. Function (Oxf). 2020;1(1):zqaa002. ' '', 'DOI': '10.1093/function/zqaa002'}, { 'key': '368_CR23', 'doi-asserted-by': 'publisher', 'first-page': '1351', 'DOI': '10.3389/fmicb.2020.01351', 'volume': '11', 'author': 'G Dev Kumar', 'year': '2020', 'unstructured': 'Dev Kumar G, Mishra A, Dunn L, Townsend A, Oguadinma IC, Bright KR, ' 'Gerba CP. Biocides and novel antimicrobial agents for the mitigation of ' 'coronaviruses. Front Microbiol. 2020;11:1351. ' '', 'journal-title': 'Front Microbiol'}, { 'issue': '1', 'key': '368_CR24', 'doi-asserted-by': 'publisher', 'first-page': '9', 'DOI': '10.1038/s41368-020-0075-9', 'volume': '12', 'author': 'X Peng', 'year': '2020', 'unstructured': 'Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of ' '2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9. ' '', 'journal-title': 'Int J Oral Sci'}, { 'issue': '7', 'key': '368_CR25', 'doi-asserted-by': 'publisher', 'first-page': '599', 'DOI': '10.1111/jopr.13220', 'volume': '29', 'author': 'AS Bidra', 'year': '2020', 'unstructured': 'Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. ' 'Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide ' 'and povidone-iodine oral antiseptic rinses. J Prosthodont. ' '2020;29(7):599–603.', 'journal-title': 'J Prosthodont'}, { 'issue': '10', 'key': '368_CR26', 'doi-asserted-by': 'publisher', 'first-page': '3707', 'DOI': '10.1007/s00784-020-03549-1', 'volume': '24', 'author': 'MJ Gottsauner', 'year': '2020', 'unstructured': 'Gottsauner MJ, Michaelides I, Schmidt B, Scholz KJ, Buchalla W, ' 'Widbiller M, Hitzenbichler F, Ettl T, Reichert TE, Bohr C, Vielsmeier V, ' 'Cieplik F. A prospective clinical pilot study on the effects of a ' 'hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. ' 'Clin Oral Investig. 2020;24(10):3707–13. ' '', 'journal-title': 'Clin Oral Investig'}, { 'issue': '5', 'key': '368_CR27', 'doi-asserted-by': 'publisher', 'first-page': '525', 'DOI': '10.3390/v12050525', 'volume': '12', 'author': 'JA Encinar', 'year': '2020', 'unstructured': 'Encinar JA, Menendez JA. Potential drugs targeting early innate immune ' 'evasion of SARS-coronavirus 2 via 2′-O-methylation of viral RNA. ' 'Viruses. 2020;12(5):525.', 'journal-title': 'Viruses'}, { 'key': '368_CR28', 'doi-asserted-by': 'publisher', 'unstructured': 'Sharshov K, Solomatina M, Kurskaya O, Kovalenko I, Kholina E, Fedorov V, ' 'Meerovich G, Rubin A, Strakhovskaya M. The photosensitizer ' 'octakis(cholinyl)zinc phthalocyanine with ability to bind to a model ' 'spike protein leads to a loss of SARS-CoV-2 infectivity in vitro when ' 'exposed to far-red LED. Viruses. 2021;13(4):643. ' '', 'DOI': '10.3390/v13040643'}, { 'key': '368_CR29', 'doi-asserted-by': 'publisher', 'unstructured': 'Sadraeian M, Zhang L, Aavani F, Biazar E, Jin D. Photodynamic viral ' 'inactivation assisted by photosensitizers. Mater Today Phys. 2022;(28). ' '', 'DOI': '10.1016/j.mtphys.2022.100882'}, { 'key': '368_CR30', 'doi-asserted-by': 'publisher', 'unstructured': '•• Santos C, da Fonseca Orcina B, Brito Reia VC, et al. Virucidal ' 'activity of the antiseptic mouthwash and dental gel containing anionic ' 'phthalocyanine derivative: In vitro study. Clin Cosmet Investig Dent. ' '2021;13:269–74.\xa0An in vitro ' 'study revealed that APD mouthwash and dental gel reduced the viability ' 'of the SARS-CoV-2 virus particles.', 'DOI': '10.2147/CCIDE.S315419'}, { 'key': '368_CR31', 'doi-asserted-by': 'publisher', 'unstructured': 'Vilhena FV, Brito Reia VC, da Fonseca Orcina B, et al. The use of ' 'antiviral Phthalocyanine mouthwash as a preventive measure against ' 'COVID-19. GMS Hyg Infect Control. 2021;16:Doc24.\xa0' '', 'DOI': '10.3205/dgkh000395'}, { 'key': '368_CR32', 'doi-asserted-by': 'publisher', 'unstructured': 'Orcina BDF, Reia VCB, Santos CA, et al. Atividade antibacteriana e ' 'antifúngica de produtos intraorais contendo ftalocianina: estudo in ' 'vitro. Praça de Pesquisa; 2021. ' '', 'DOI': '10.21203/'}, { 'key': '368_CR33', 'unstructured': 'Organização Mundial da Saúde. Gestão clínica da COVID-19: orientação ' 'provisória, 27 de maio de 2020. Organização Mundial da Saúde. 2020.\xa0' ''}, { 'key': '368_CR34', 'doi-asserted-by': 'publisher', 'unstructured': 'da Fonseca Orcina B, Vilhena FV, Cardoso de Oliveira R, Marques da Costa ' 'Alves L, Araki K,\xa0Toma SH, et al. A phthalocyanine derivate mouthwash ' 'to gargling/rinsing as an option to reduce clinical symptoms of ' 'COVID-19: Case Series. Clin Cosmet Investig Dent. 2021;13:47–50. ' '', 'DOI': '10.2147/CCIDE.S295423'}, { 'issue': '1', 'key': '368_CR35', 'doi-asserted-by': 'publisher', 'first-page': '67', 'DOI': '10.4067/S0718-381X2021000100067', 'volume': '15', 'author': 'B da Fonseca Orcina', 'year': '2021', 'unstructured': 'da Fonseca Orcina B, Santos PSS. Oral manifestation COVID-19 and the ' 'rapid resolution of symptoms post-phtalox treatment: a case series. Int ' 'J Odontostomat. 2021;15(1):67–70.', 'journal-title': 'Int J Odontostomat'}, { 'key': '368_CR36', 'unstructured': 'Centers for Disease Control and Prevention (CDC) SARS-CoV-2 variant ' 'classifications and definitions. Atlanta: CDC. 2021.\xa0' ''}, { 'key': '368_CR37', 'doi-asserted-by': 'publisher', 'unstructured': '•• Vilhena FV, da Fonseca Orcina B, Lemos L, Less JCF, Pinto I, da Silva ' 'Santos PS. Elimination of SARS-CoV-2 in nasopharynx and oropharynx after ' 'use of an adjuvant gargling and rinsing protocol with an antiseptic ' 'mouthwash. Einstein (São Paulo). 2022;19:eCE6999. ' ' Use of ' 'phthalocyanine derivative mouthwash caused the elimination of the ' 'SARS-CoV-2 virus in different strains.', 'DOI': '10.31744/einstein_journal/2021CE6999'}, { 'key': '368_CR38', 'doi-asserted-by': 'publisher', 'unstructured': '• Reia VCB, Bastos RS, Vilhena FV, et al. Population-based virucidal ' 'phthalocyanine gargle/rinse protocol to reduce the risk of coronavirus ' 'disease-2019: a community trial. Res Sq [Preprint]. 2021. ' ' The use of the APD ' 'mouthwash protocol appears to lower the population-level incidence of ' 'COVID-19.', 'DOI': '10.21203/'}, { 'key': '368_CR39', 'doi-asserted-by': 'publisher', 'unstructured': '•• da Silva Santos PS, da Fonseca Orcina B, Machado RRG,\xa0Vilhena FV, ' 'da Costa Alves LM, Zangrando MSR, et al. Beneficial effects of a ' 'mouthwash containing an antiviral phthalocyanine derivative on the ' 'length of hospital stay for COVID-19: randomised trial. Sci Rep. ' '2021;11(1):19937.\xa0Using ' 'mouthwashes with a substance that has antiviral effects against the ' 'SARS-CoV-2 virus, according to a randomized clinical trial, can reduce ' "patients' symptoms and the spread of infection.", 'DOI': '10.1038/s41598-021-99013-5'}, { 'key': '368_CR40', 'doi-asserted-by': 'publisher', 'unstructured': 'Poleti ML, Gregório D, Bistaffa AGI, et al. The use of a mouthwash and a ' 'dentifrice containing antimicrobial phthalocyanine derivative on the ' 'reduction of clinical symptoms of COVID-19: a randomized triple-blinded ' 'clinical trial. Res Sq [Preprint]. 2021. ' '', 'DOI': '10.21203/'}, { 'issue': '2', 'key': '368_CR41', 'doi-asserted-by': 'publisher', 'first-page': '29', 'DOI': '10.1159/000246027', 'volume': '195', 'author': 'R Kawana', 'year': '1997', 'unstructured': 'Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, ' 'Yanagi K, Yamada A, Morita O, Yoshida Y, Furuya Y, Chiba S. Inactivation ' 'of human viruses by povidone-iodine in comparison with other ' 'antiseptics. Dermatology. 1997;195(2):29–35. ' '', 'journal-title': 'Dermatology'}, { 'issue': '1', 'key': '368_CR42', 'doi-asserted-by': 'publisher', 'first-page': '32', 'DOI': '10.1159/000057722', 'volume': '204', 'author': 'T Nagatake', 'year': '2002', 'unstructured': 'Nagatake T, Ahmed K, Oishi K. Prevention of respiratory infections by ' 'povidone-iodine gargle. Dermatology. 2002;204(1):32–6. ' '', 'journal-title': 'Dermatology'}, { 'issue': '3', 'key': '368_CR43', 'doi-asserted-by': 'publisher', 'first-page': '669', 'DOI': '10.1007/s40121-020-00316-3', 'volume': '9', 'author': 'DE Anderson', 'year': '2020', 'unstructured': 'Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, ' 'Jenkins TM, Hadjiat Y, Eggers M. Povidone-iodine demonstrates rapid in ' 'vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 ' 'disease. Infect Dis Ther. 2020;9(3):669–75. ' '', 'journal-title': 'Infect Dis Ther'}, { 'issue': '12', 'key': '368_CR44', 'doi-asserted-by': 'publisher', 'first-page': '900', 'DOI': '10.1038/s41415-020-1794-1', 'volume': '228', 'author': 'P Hassandarvish', 'year': '2020', 'unstructured': 'Hassandarvish P, Tiong V, Sazaly AB, Mohamed NA, Arumugam H, ' 'Ananthanarayanan A, Qasuri M, Hadjiat Y. Povidone iodine gargle and ' 'mouthwash. Br Dent J. 2020;228(12):900. ' '', 'journal-title': 'Br Dent J'}, { 'key': '368_CR45', 'doi-asserted-by': 'publisher', 'unstructured': 'Martinez Lamas L, Diz Dios P, Perez Rodriguez MT, Del Campo P, Cabrera ' 'Alvargonzalez JJ, Lopez Dominguez AM, Fernandez Feijoo J, Diniz Freitas ' 'M, Limeres Posse J. Is povidone-iodine mouthwash effective against ' 'SARS-CoV-2? First in vivo tests. Oral Dis. 2020. [epub ahead of print 2 ' 'Jul 2020].', 'DOI': '10.1111/odi.13526'}, { 'issue': '8', 'key': '368_CR46', 'doi-asserted-by': 'publisher', 'first-page': 'e00576', 'DOI': '10.1128/AAC.00576-20', 'volume': '64', 'author': 'X Mao', 'year': '2020', 'unstructured': 'Mao X, Auer DL, Buchalla W, Hiller KA, Maisch T, Hellwig E, Al-Ahmad A, ' 'Cieplik F. Cetylpyridinium chloride: mechanism of action, antimicrobial ' 'efficacy in biofilms, and potential risks of resistance. Antimicrob ' 'Agents Chemother. 2020;64(8):e00576-e620. ' '', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '5', 'key': '368_CR47', 'doi-asserted-by': 'publisher', 'first-page': '481', 'DOI': '10.1177/0022034520914246', 'volume': '99', 'author': 'L Meng', 'year': '2020', 'unstructured': 'Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and ' 'future challenges for dental and oral medicine. J Dent Res. ' '2020;99(5):481–7.', 'journal-title': 'J Dent Res'}, { 'issue': '1', 'key': '368_CR48', 'doi-asserted-by': 'publisher', 'first-page': '27', 'DOI': '10.1111/idh.12402', 'volume': '18', 'author': 'BWM Van Swaaij', 'year': '2020', 'unstructured': 'Van Swaaij BWM, van der Weijden GAF, Bakker EWP, Graziani F, Slot DE. ' 'Does chlorhexidine mouthwash, with an anti-discoloration system, reduce ' 'tooth surface discoloration without losing its efficacy? A systematic ' 'review and meta-analysis. Int J Dent Hyg. 2020;18(1):27–43. ' '', 'journal-title': 'Int J Dent Hyg'}, { 'key': '368_CR49', 'unstructured': 'How Does COVIXYL-V Nasal Spray Work? Available online:\xa0' ' Accessed 14 ' 'Jun 2023.'}, { 'issue': '10', 'key': '368_CR50', 'doi-asserted-by': 'publisher', 'first-page': '1612', 'DOI': '10.3390/pharmaceutics13101612', 'volume': '13', 'author': 'B Pilicheva', 'year': '2021', 'unstructured': 'Pilicheva B, Boyuklieva R. Can the nasal cavity help tackle COVID-19? ' 'Pharmaceutics. 2021;13(10):1612. ' '', 'journal-title': 'Pharmaceutics'}], 'container-title': 'Current Oral Health Reports', 'original-title': [], 'language': 'en', 'link': [ { 'URL': '', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 5, 1]], 'date-time': '2024-05-01T12:54:45Z', 'timestamp': 1714568085000}, 'score': 1, 'resource': {'primary': {'URL': ''}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 2, 19]]}, 'references-count': 50, 'journal-issue': {'issue': '2', 'published-online': {'date-parts': [[2024, 6]]}}, 'alternative-id': ['368'], 'URL': '', 'relation': {}, 'ISSN': ['2196-3002'], 'subject': [], 'container-title-short': 'Curr Oral Health Rep', 'published': {'date-parts': [[2024, 2, 19]]}, 'assertion': [ { 'value': '1 February 2024', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '19 February 2024', 'order': 2, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors declare no competing interests.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of Interest'}}, { 'value': 'This article does not contain any studies with human or animal subjects ' 'performed by any of the present authors.', 'order': 3, 'name': 'Ethics', 'group': { 'name': 'EthicsHeading', 'label': 'Human and Animal Rights and Informed Consent'}}]}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop